Circ Cardiovasc Interv 5(2):288295 Lnborg J, Vejlstrup N, Kelbk H, Btker HE, Kim WY, Mathiasen AB et al (2012b) Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
GLP-1s were initially developed to help people with type 2 diabetes control their blood sugar, but the weight loss side effects have made them a hot commodity
Despite these issues, industry sentiment is that gaps in adoption are closing rapidly
Bull Am Meteor Soc 101(8):E1439E1451
303,304 Van Es et al 303 showed a statistically significant increase in ejection fraction among 13 patients (mean, 48.6% versus 42.4%) after 3 months of L-carnitine therapy (1 g IV after each hemodialysis session)
Many Gram-negative bacteria, such as E